back to US directory
us clinical guidance

Pelvic inflammatory disease

CDC low-threshold diagnosis, empiric broad treatment, hospitalization criteria, partner care and 72-hour response review for acute PID.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Sexually active adolescents and adults with suspected acute upper-genital-tract infection. Pregnancy, postprocedural infection, tubo-ovarian abscess, sepsis and uncertain surgical emergencies require hospital or specialist pathways; chronic pelvic pain alone is not automatically PID.
sources for this section:CDC PID 2021

The Bottom Line

  • Maintain a low threshold for empiric treatment when pelvic or lower-abdominal pain has no better cause and examination shows cervical-motion, uterine or adnexal tenderness.
  • A negative gonorrhea or chlamydia test does not exclude upper-tract infection; CDC outpatient regimens provide gonococcal, chlamydial and anaerobic coverage.
  • Start treatment as soon as presumptive PID is diagnosed because delay increases risk of infertility, ectopic pregnancy and chronic pelvic pain.
  • Test every patient with PID for gonorrhea, chlamydia, HIV and syphilis and evaluate pregnancy and alternative surgical diagnoses.
  • Reassess clinical improvement within 72 hours and hospitalize or broaden diagnostics when outpatient response is absent.
sources for this section:CDC PID 2021

Practical clinical workflow

1
Take a confidential sexual and contraceptive history and assess pain, bleeding, discharge, fever, pregnancy, vomiting, prior PID, procedures and risk of coercion or assault.
2
Check vital signs, abdominal and pelvic findings, pregnancy test and site-specific nucleic-acid testing, adding urinalysis, microscopy, blood tests or imaging according to severity.
3
Select the CDC outpatient or parenteral regimen, treat nausea and pain, and remove an intrauterine device only when the source-supported follow-up decision indicates it.
4
Counsel abstinence until treatment is complete, symptoms have resolved and partners are treated; arrange partner evaluation for contacts in the preceding 60 days.
5
Retest chlamydial or gonococcal PID at three months and address ongoing contraception, STI prevention and fertility or pain sequelae.
sources for this section:CDC PID 2021

Safety boundaries and escalation

  • Pregnancy, severe illness, vomiting, high fever, tubo-ovarian abscess, inability to follow outpatient therapy or inability to exclude appendicitis or another surgical emergency favors hospitalization.
  • Hemodynamic instability, peritonitis, sepsis, acute severe unilateral pain or ectopic-pregnancy concern requires immediate emergency and gynecologic assessment.
  • Do not wait for imaging or every test result before treating a clinically supported case; early empiric therapy is central to preventing reproductive harm.
  • Persistent mass, fever or tenderness despite treatment requires abscess and alternative-diagnosis evaluation rather than repeated outpatient antibiotics.
sources for this section:CDC PID 2021

Localization

CDC STI regimens and US state partner-treatment law govern this pathway. Local gonococcal susceptibility, emergency gynecology access and reporting rules must be checked.
sources for this section:CDC PID 2021

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Centers for Disease Control and PreventionSexually Transmitted Infections Treatment Guidelines, 2021 — Pelvic Inflammatory DiseaseMMWR 2021;70(No. RR-4) · published 2021-07-23 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.